These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32223609)

  • 41. AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.
    Spooner JJ; Gandhi PK; Connelly SB
    J Manag Care Pharm; 2007; 13(1):37-43. PubMed ID: 17269835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacy benefit management companies.
    Taniguchi R
    Am J Health Syst Pharm; 1995 Sep; 52(17):1915-7. PubMed ID: 8528857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda.
    Gembarski J; Couto J; Wilson M;
    J Manag Care Spec Pharm; 2020 Apr; 26(4):375-381. PubMed ID: 32130069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
    Cross M
    Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
    [No Abstract]   [Full Text] [Related]  

  • 45. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A managed care timeline, 1988-1996.
    Bell N
    Med Interface; 1997 Jan; 10(1):66-72, 75-80. PubMed ID: 10164507
    [No Abstract]   [Full Text] [Related]  

  • 47. Manufacturer response to AMCP Format dossier requests.
    Lyles A; Watkins JD
    J Manag Care Pharm; 2007 Apr; 13(3):290-1; author reply 291-2. PubMed ID: 17407398
    [No Abstract]   [Full Text] [Related]  

  • 48. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN; Avey SG; Sullivan SD
    Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DAKOTACARE's integrated medical and pharmacy management: enhancing value.
    Jones R
    S D Med; 2014 May; 67(5):209. PubMed ID: 24851471
    [No Abstract]   [Full Text] [Related]  

  • 51. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The drug formulary decision-making process.
    Brehany J; Cohen P; Sax MJ
    Healthplan; 1999; 40(3):85-92. PubMed ID: 10538088
    [No Abstract]   [Full Text] [Related]  

  • 54. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Academy of Managed Care Pharmacy's concepts in managed care pharmacy: prior authorization and the formulary exception process.
    Fallik B
    J Manag Care Pharm; 2005 May; 11(4):358-61. PubMed ID: 15871651
    [No Abstract]   [Full Text] [Related]  

  • 56. Raising the bar in the formulary decision process.
    Navarro RP
    Manag Care Interface; 1999 Jul; 12(7):51, 54. PubMed ID: 10539501
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in P & T Committee function, role of pharmacists under managed care, and more.
    Hosp Formul; 1993 Dec; 28(12):963, 967-8, 970. PubMed ID: 10183991
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug benefits in managed care: seeking ethical guidance from the formulary?
    Fins JJ
    J Am Geriatr Soc; 1998 Mar; 46(3):346-50. PubMed ID: 9514384
    [No Abstract]   [Full Text] [Related]  

  • 59. The management of a hospital formulary.
    Sutters CA
    J Clin Pharm Ther; 1990 Feb; 15(1):59-76. PubMed ID: 2318917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use.
    Vargas-Rivas JE; Sabater-Hernández D; Calleja-Hernández MA; Faus MJ; Martínez-Martínez F
    Int J Clin Pharm; 2011 Oct; 33(5):719-21; author reply 722-3. PubMed ID: 21847687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.